Important Notice
The products are for research and development purposes only.
CBL-514&Retatrutide Injection Pen Kit
The active substance in the pen is CBL-514 and retatrutide. Retatrutide mimics the hormones GLP-1 and GIP, normally released in the gut after eating. This activates neurons in the brain that signals fullness to your body and suppresses appetite.CBL-514 is a first-in-class,non-surgicalinjectable drug designed to reduce localized subcutaneous fat. It works by inducing programmed cell death (apoptosis) in fat cells without causing necrosis or damage to surrounding tissue. It is very important you maintain daily your diet and exercise plan as advised by your doctor, nurse, or pharmacist. Retatrutide is also used to control blood sugar levels for patients with diabetes. If you have diabetes you must consult with your doctor before using any more Retatrutide.
Suitable R&D Applications
Stability Testing
- • Thermal, enzymatic, and oxidative degradation studies
- • Shelf-life evaluation & formulation robustness
Formulation Development
- • Enhances solubility, bioavailability, and structural integrity
- • Tailored for injectable, topical, and research-grade use
Excipient Compatibility Testing
- • Evaluates interactions between peptides & inactive components
- • Ensures safety, stability, and performance
Protease Resistance Evaluation
- • Evaluates interactions between peptides & inactive components
- • Ensures safety, stability, and performance
Encapsulation & Carrier Systems
- • Liposomes, microspheres, and other delivery vehicles
- • Protects peptides & enables controlled release
Administration Route Assessment
- • Parenteral delivery (injectables)
- • Dermal absorption (cosmetic/topical)
- • In vitro research applications